Platelet-rich plasma and platelet-rich fibrin in oral surgery: A narrative review
- PMID: 37023345
- DOI: 10.17219/dmp/147298
Platelet-rich plasma and platelet-rich fibrin in oral surgery: A narrative review
Abstract
Platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) are biological products derived from the plasma fraction of autologous blood that have a platelet concentration above that of the original blood. Cytokines and growth factors are present in platelet-based preparations, and their application has gained great attention in dentistry. The aim of this review was to comprehensively examine the latest scientific evidence on the use of PRF and PRP in oral surgery, and to describe current operational protocols. Platelet-rich fibrin is used after third molar extractions, in the treatment of alveolar osteitis and trismus, and in implant surgery. Platelet-rich plasma is utilized in sinus lift procedures, after tooth extractions, and in patients undergoing the treatment of bisphosphonate-related osteonecrosis of the jaw. Based on this review, plenty of data indicates that the PRF-PRP usage in oral surgery shows promising results. However, no consistent protocols have been presented in the analyzed articles. Further research is needed to provide clinicians with evidence-based clinical recommendations and to develop protocols on the use of these preparations in dental surgery.
Keywords: dental surgery; operative protocols; platelet-rich fibrin; platelet-rich plasma.
Similar articles
-
Current knowledge and perspectives for the use of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in oral and maxillofacial surgery part 2: Bone graft, implant and reconstructive surgery.Curr Pharm Biotechnol. 2012 Jun;13(7):1231-56. doi: 10.2174/138920112800624472. Curr Pharm Biotechnol. 2012. PMID: 21740370 Review.
-
Positive impact of Platelet-rich plasma and Platelet-rich fibrin on viability, migration and proliferation of osteoblasts and fibroblasts treated with zoledronic acid.Sci Rep. 2019 Jun 5;9(1):8310. doi: 10.1038/s41598-019-43798-z. Sci Rep. 2019. PMID: 31165745 Free PMC article.
-
Evaluation of the Efficacy of Platelet-Rich Plasma versus Platelet-Rich Fibrin in Alleviating Postoperative Inflammatory Morbidities after Lower Third Molar Surgery: A Double-Blind Randomized Study.West Afr J Med. 2022 Apr 29;39(4):343-349. West Afr J Med. 2022. PMID: 35488875 Clinical Trial.
-
Tooth extractions in patients under antiresorptive therapy for osteoporosis: Primary closure of the extraction socket with a mucoperiosteal flap versus application of platelet-rich fibrin for the prevention of antiresorptive agent-related osteonecrosis of the jaw.J Craniomaxillofac Surg. 2020 Apr;48(4):444-451. doi: 10.1016/j.jcms.2020.02.006. Epub 2020 Feb 18. J Craniomaxillofac Surg. 2020. PMID: 32122726
-
Platelet-Rich Fibrin in Oral Surgery and Implantology: A Narrative Review.Transfus Med Hemother. 2022 Dec 22;50(4):348-359. doi: 10.1159/000527526. eCollection 2023 Aug. Transfus Med Hemother. 2022. PMID: 37767284 Free PMC article. Review.
Cited by
-
Clinical Outcomes After Dental Surgery with Two Antiseptic Protocols.Dent J (Basel). 2024 Nov 28;12(12):389. doi: 10.3390/dj12120389. Dent J (Basel). 2024. PMID: 39727446 Free PMC article.
-
Bibliometric Analysis of Platelet-Rich Plasma Treatment for Hair Restoration, Facial Rejuvenation, Dental Procedures, and Gynecological Rejuvenation.Skin Appendage Disord. 2025 Apr;11(2):166-175. doi: 10.1159/000541528. Epub 2024 Oct 22. Skin Appendage Disord. 2025. PMID: 40177000
-
Novel topical dressing for dry socket and comparison of its efficacy with that of Alvogyl®: A randomized controlled clinical trial.Med Oral Patol Oral Cir Bucal. 2025 Jan 1;30(1):e41-e48. doi: 10.4317/medoral.26820. Med Oral Patol Oral Cir Bucal. 2025. PMID: 39582403 Free PMC article. Clinical Trial.
-
A Comparison of the Dimensional Characteristics and Plasma Parameters of Different Centrifuges Used for the Preparation of Autologous Platelet Concentrates: A Randomized Correlational Study.Materials (Basel). 2025 Jan 17;18(2):414. doi: 10.3390/ma18020414. Materials (Basel). 2025. PMID: 39859885 Free PMC article.
-
Perspectives on the use of decellularized/devitalized and lyophilized human perinatal tissues for bone repair: Advantages and remaining challenges.Mater Today Bio. 2024 Nov 26;30:101364. doi: 10.1016/j.mtbio.2024.101364. eCollection 2025 Feb. Mater Today Bio. 2024. PMID: 39811604 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials